The NFE2L1-high/NDUFA9-low group was more enriched in EMT signature genes than the other group (Figure 1K), implying that the NDUFA9-associated NFE2L1 expression may play a key role in hepatoma cell invasiveness. The gene discussed is NFE2L1; the disease is hepatocellular carcinoma.